Patents by Inventor Raymond A. Hartman
Raymond A. Hartman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11979789Abstract: A communication system with a master device configured to determine location information in real-time with respect to a portable device. The master device may direct one or more monitor devices to monitor communications that occur over a primary communication link. The monitor devices may sense characteristic information about the signal from the portable device, and communicate this characteristic information to the master device via an auxiliary communication link. The communication system may determine location of the portable device, authenticate the portable device, determine whether the portable device is authorized to allow or initiate an action, and command or enable an action with respect to equipment.Type: GrantFiled: July 9, 2021Date of Patent: May 7, 2024Assignee: DENSO CORPORATIONInventors: Raymond Michael Stitt, Eric Smith, Michael Stroud, Robert Hartman, Karl Jager, Antonio Fominaya, IV
-
Publication number: 20230285451Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: ApplicationFiled: November 14, 2022Publication date: September 14, 2023Inventors: Roy S. RUBINFELD, Raymond A. HARTMAN, Sandy T. FELDMAN
-
Publication number: 20230058802Abstract: A guided retainer for movably coupling a holder to a plate of a stamping die for use in a press including a pin having an enlarged portion. A bushing received on and slidable relative to the pin into an abutting relationship with the enlarged portion. When the guided retainer is assembled with the holder and the plate, the guided retainer is capable of transferring motion of the holder to the plate during movement of the press to an opened position for insertion of a workpiece into the stamping die. The pin includes a groove and a retainer plate that is received in the groove. A stamping die configured to be used in a press to modify a workpiece. The stamping die including a holder that is adapted to be coupled to the press. A plate that is spaced apart from the holder and a guided retainer.Type: ApplicationFiled: October 12, 2022Publication date: February 23, 2023Inventors: Gezim Miftari, Jon Raymond Hartman, Jeffrey William Ouimet, Kevin John Latouf
-
Patent number: 11504759Abstract: A guided retainer for movably coupling a holder to a plate of a stamping die for use in a press including a pin having an enlarged portion. A bushing received on and slidable relative to the pin into an abutting relationship with the enlarged portion. When the guided retainer is assembled with the holder and the plate, the guided retainer is capable of transferring motion of the holder to the plate during movement of the press to an opened position for insertion of a workpiece into the stamping die. The pin includes a groove and a retainer plate that is received in the groove. A stamping die configured to be used in a press to modify a workpiece. The stamping die including a holder that is adapted to be coupled to the press. A plate that is spaced apart from the holder and a guided retainer.Type: GrantFiled: July 17, 2020Date of Patent: November 22, 2022Assignee: Anchor Lamina America, Inc.Inventors: Gezim Miftari, Jon Raymond Hartman, Jeffrey William Ouimet, Kevin John Latouf
-
Patent number: 11497766Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: GrantFiled: August 3, 2020Date of Patent: November 15, 2022Assignee: CXL OPHTHALMICS, LLCInventors: Roy S. Rubinfeld, Raymond A. Hartman, Sandy T. Feldman
-
Publication number: 20220211542Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: ApplicationFiled: October 1, 2021Publication date: July 7, 2022Inventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman
-
Patent number: 11135090Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: GrantFiled: September 11, 2018Date of Patent: October 5, 2021Assignee: CXL OPHTHALMICS, LLCInventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman
-
Patent number: 11033429Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: GrantFiled: September 11, 2018Date of Patent: June 15, 2021Assignee: CXL OPHTHALMICS, LLCInventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman
-
Publication number: 20210023604Abstract: A guided retainer for movably coupling a holder to a plate of a stamping die for use in a press including a pin having an enlarged portion. A bushing received on and slidable relative to the pin into an abutting relationship with the enlarged portion. When the guided retainer is assembled with the holder and the plate, the guided retainer is capable of transferring motion of the holder to the plate during movement of the press to an opened position for insertion of a workpiece into the stamping die. The pin includes a groove and a retainer plate that is received in the groove. A stamping die configured to be used in a press to modify a workpiece. The stamping die including a holder that is adapted to be coupled to the press. A plate that is spaced apart from the holder and a guided retainer.Type: ApplicationFiled: July 17, 2020Publication date: January 28, 2021Inventors: Kevin John Latouf, Gezim Miftari, Jon Raymond Hartman, Jeffrey William Ouimet
-
Publication number: 20200360427Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: ApplicationFiled: August 3, 2020Publication date: November 19, 2020Inventors: Roy S. RUBINFELD, Raymond A. HARTMAN, Sandy T. FELDMAN
-
Patent number: 10729716Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: GrantFiled: September 20, 2018Date of Patent: August 4, 2020Assignee: CXL OPHTHALMICS, LLCInventors: Roy S. Rubinfeld, Raymond A. Hartman, Sandy T. Feldman
-
Patent number: 10285857Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: GrantFiled: September 21, 2016Date of Patent: May 14, 2019Assignee: CXL OPHTHALMICS, LLCInventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman
-
Publication number: 20190022134Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: ApplicationFiled: September 20, 2018Publication date: January 24, 2019Inventors: Roy S. Rubinfeld, Raymond A. Hartman (Deceased), Sandy T. Feldman
-
Publication number: 20190008678Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: ApplicationFiled: September 11, 2018Publication date: January 10, 2019Inventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman (deceased)
-
Publication number: 20190008679Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: ApplicationFiled: September 11, 2018Publication date: January 10, 2019Inventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman (deceased)
-
Patent number: 10092594Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: GrantFiled: October 26, 2016Date of Patent: October 9, 2018Assignee: CXL Ophthalmics, LLCInventors: Roy S. Rubinfeld, Raymond A. Hartman, Sandy T. Feldman
-
Patent number: 10070658Abstract: A fish processing apparatus. The fish processing apparatus includes a cutting board, a first clamp and a second clamp. The first clamp is coupled to the cutting board. The second clamp is slidably coupled to the cutting board so that the second clamp may slide towards and away from the first clamp.Type: GrantFiled: May 17, 2018Date of Patent: September 11, 2018Inventor: George Raymond Hartman
-
Patent number: 9622911Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: GrantFiled: March 12, 2014Date of Patent: April 18, 2017Assignee: CXL Ophthalmics, LLCInventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman
-
Publication number: 20170071978Abstract: Methods and compositions for treating various indications by lessening oxidative stress in a patient are provided. A pharmaceutical composition comprises between about 0.001% to about 10.0%, or more specifically between about 0.015% to about 5%, sodium iodide or catalase by weight. The iodine ion or the catalase dissociates hydrogen peroxide into water and molecular oxygen to interrupt biological events that result in negative side effects. The pharmaceutical composition further comprises in some cases a reducing agent or various carrier materials. The pharmaceutical composition is in some cases formulated for a variety of delivery methods.Type: ApplicationFiled: October 26, 2016Publication date: March 16, 2017Inventors: Roy S. Rubinfeld, Raymond A. Hartman, Sandy T. Feldman
-
Publication number: 20170065826Abstract: Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.Type: ApplicationFiled: September 21, 2016Publication date: March 9, 2017Inventors: Roy S. Rubinfeld, Sandy T. Feldman, Kevin E. Daly, Raymond A. Hartman